21 May 2009
Influence of viral infections on allografts function and acute graft rejection (agr) in both donors and recipients
P Jurkowski, A Mikłaszewicz, M Cićkiewicz, P Orszulak, M Fiedor, Z Lewandowski, P FiedorAnn Transplant 2009; 14(1): 74-74 :: ID: 880471
Abstract
Background: Virus infections play a key role and directly influence allograft
function in recipients under chronic immunosuppression. The aim of this study was to evaluate the infl uence of CMV, EBV, HBV and HCV virus infections in both donors and recipients on graft stability.
Material/Methods: The medical histories of 171 kidney and liver allograft recipients were analyzed in search of viral infections. Next, every recipient was matched with their donors. It was evaluated how different viral infections influence the time of acute graft rejection.
Results: There was no significant difference in the time of acute rejection time between HBVAg positive and HBVAg negative recipients (p>0.05). Seven months after transplantation, the number of Anti-HCV positive recipients after AGR was twice as big as the number of Anti-HCV negative patients (p=0.0176). Seven months after transplantation, the number of CMV-IgM positive recipients after AGR was three times as big as the number of CMV-IgM negative patients(p=0.0292). There was found no correlation between EBV infection and acute rejection time.
Conclusions: Our data strongly indicate that both HCV and CMV virus infections worsen allograft stability in transplant recipients and immunosuppression is an independent risk factor.
Keywords: CMV infections, HBV infection, HCV infection, viral infections
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






